These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23982253)

  • 1. Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
    Müller SA; Mehrabi A; Rahbari NN; Warschkow R; Elbers H; Leowardi C; Fonouni H; Tarantino I; Schemmer P; Schmied BM; Büchler MW
    Ann Surg Oncol; 2014 Jan; 21(1):155-64. PubMed ID: 23982253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Warschkow R; Güller U; Köberle D; Müller SA; Steffen T; Thurnheer M; Schmied BM; Tarantino I
    Ann Surg; 2014 Jan; 259(1):131-8. PubMed ID: 23470578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
    Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
    Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
    Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma.
    Zhang GW; Lin JH; Qian JP; Zhou J
    Ann Surg Oncol; 2014 Oct; 21(11):3628-37. PubMed ID: 24781504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood transfusion does not adversely affect survival after elective colon cancer resection: a propensity score analysis.
    Tarantino I; Ukegjini K; Warschkow R; Schmied BM; Steffen T; Ulrich A; Müller SA
    Langenbecks Arch Surg; 2013 Aug; 398(6):841-9. PubMed ID: 23838797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Kulu Y; Tarantio I; Warschkow R; Kny S; Schneider M; Schmied BM; Büchler MW; Ulrich A
    Ann Surg Oncol; 2015; 22(6):2059-67. PubMed ID: 25348782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
    Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
    Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.
    Ercolani G; Vetrone G; Grazi GL; Aramaki O; Cescon M; Ravaioli M; Serra C; Brandi G; Pinna AD
    Ann Surg; 2010 Jul; 252(1):107-14. PubMed ID: 20531002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
    Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
    J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.